Edwards should have bought us ages ago for peanuts, as insurance...

Edwards should have bought us ages ago for peanuts, as insurance if nothing else. They've seen startups come and go and probably dismissed us early on, to be fair we looked like we were sunk at one stage. It's easy to get blinded by your past success though, and they simply can't keep up with how fast we are moving. The train has left the station but they aren't even on the platform yet.
Now they face a rapidly increasing purchase price for a company that is outpacing them every which way on the science. The opportunity for a cheap acquisition is gone. So either they pay up big, suffer massive dilution for their existing shareholders but ensure their survival - but that admits they got it wrong not taking us out earlier too. Or they continue to back their own research and ability to defend their market position ... head in the sand, but whatever. I agree with you, I think they will do this too, we don't know what R&D they have but our medical advisory board do and my view is that Edwards days are already numbered. If there is an offer to be made a second tier player has most to gain and least to lose, that's my guess where it will come from.
That said, my view is most value will be achieved by us commercialising, we just need to be more patient. That doesn't mean we wait years for huge share price appreciation, it will happen along the way and people can exit on market when they are ready. But why sell cheap to a buyout offer? Given the market size and our superior science we will be worth $50b in 10 years. Or to put it in terms every Aussie understands, why would you sell your $2m home to someone for $200k just because they knock on your door with a suitcase of cash?